NCT02027805View on ClinicalTrials.gov

Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 5, 2014

Primary Completion Date

September 7, 2016

Study Completion Date

November 3, 2016

Conditions
Graft vs Host Disease
Interventions
BIOLOGICAL

T-Guard

Trial Locations (2)

48149

University Hospital Münster, Münster

6525 GA

Radboudumc, Nijmegen

Sponsors

Lead Sponsor

Xenikos
All Listed Sponsors
lead

Xenikos

INDUSTRY

NCT02027805 - Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD | Biotech Hunter | Biotech Hunter